Related Experiment Video
Updated: Jan 5, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Efficacy of newly generated short antimicrobial cationic lipopeptides against methicillin-resistant Staphylococcus
Katarzyna E Greber1, Melanie Roch2, Mauro A Rosato3
1Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland.
Introduction:
Infection caused by methicillin-resistant Staphylococcus aureus (S. aureus) (MRSA) is a serious clinical challenge and research to develop new antimicrobials is imperative.
Methods:
This study investigated the in vitro and in vivo efficacy of the short cationic dialkyl lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2. The antibacterial efficacy of (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2 was evaluated in representative clinical methicillin-susceptible S. aureus and MRSA strains by both in vitro (MIC, time-kill curve) and in vivo (wax worms model) approaches.
Results:
These studies revealed that both (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2 have rapid bactericidal activity, with a decrease of > 3 log10 colony forming units (CFU)/mL achieved in the first 6 hours of treatment. Furthermore, (C10)2-KKKK-NH2 performed similarly to daptomycin, with a sustained bacterial killing after 24 hours. Wax worms infected and treated with these lipopeptides showed a decreased survival rate of 90% to 50% within the first day of treatment. Scanning electron microscopy determined that the effect of the short lipopeptides in S. aureus was associated with important morphological structural changes that may suggest cell membrane perturbation.
Conclusion:
These findings suggest that the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2 may be potential new options for treating MRSA infections.
Insights
New short cationic lipopeptides show rapid bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA). These compounds demonstrate potential as novel antimicrobial agents for treating challenging MRSA infections.
Area of Science:
- Antimicrobial research
- Drug discovery
- Infectious diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant clinical threat.
- Development of novel antimicrobials is crucial to combat MRSA infections.
Purpose of the Study:
- To evaluate the in vitro and in vivo efficacy of two short cationic dialkyl lipopeptides: (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2.
- To assess their potential as new therapeutic options against MRSA.
Main Methods:
- Antibacterial activity was assessed using minimum inhibitory concentration (MIC) and time-kill curve assays.
- In vivo efficacy was evaluated in a wax worm infection model.
- Morphological changes were observed using scanning electron microscopy.
Main Results:
- Both lipopeptides exhibited rapid bactericidal activity, reducing bacterial load by over 3 log10 CFU/mL within 6 hours.
- (C10)2-KKKK-NH2 demonstrated sustained bacterial killing comparable to daptomycin over 24 hours.
- Treatment significantly improved survival rates in infected wax worms and caused structural damage to S. aureus, suggesting cell membrane perturbation.
Conclusions:
- The short cationic lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2 show promising antimicrobial properties.
- These compounds represent potential novel therapeutic agents for treating MRSA infections.
More Related Videos
11:52Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Combined Effects of Drugs: Synergism
Such synergistic combinations...